Impact of COVID-19 on the Economy and Orders
First written in FY2020-Q2. 7 of 17 entries say "Materialised", first in FY2020-Q3. Latest entry: FY2026-H1.
Micron Machinery moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2020: 112 of 175 companies on the "Worse" side.
35 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new business risks or material changes to the business risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in the risk of COVID-19 affecting the economy and order intake. - FY2024-Q2RestatedAnnual report
「During the second quarter of the current consolidated cumulative period, the Japanese economy continued to show signs of a gradual recovery as socioeconomic activity normalized following the reclassification of COVID-19 as a Class 5 disease, supported by the effects of various policies, although some stagnation was observed.」
The disclosure describes the continued normalization of socioeconomic activity and gradual recovery following the reclassification of COVID-19 as a Class 5 disease. - FY2024-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, the Japanese economy showed signs of a gradual recovery as socioeconomic activity continued to normalize following the reclassification of COVID-19 as a Class 5 disease, supported by the effects of various policies.」
The disclosure describes the normalization of socioeconomic activity following the reclassification of COVID-19 as a Class 5 disease, reconfirming the trend toward reduced pandemic-related impacts and economic normalization from the previous period. - FY2023Easing of the impact of the infection and normalization of economic activityAnnual report
「With COVID-19 reclassified as a Class 5 disease, activity restrictions were lifted and socioeconomic activity began returning to normal. Supported by the effects of various policies, the economy showed signs of a gradual recovery.」
Instead of the specific impacts previously described, such as restrictions on business activities and delivery delays, this period focuses on the reclassification of COVID-19 as a Class 5 disease, the lifting of activity restrictions and the normalization of socioeconomic activity. - FY2023-Q3RestatedAnnual report
「The Japanese economy during the nine months ended 31 December showed signs of a moderate recovery under the “living with COVID-19” environment, partly due to the effects of various government policies.」
It describes an economic recovery under the “living with COVID-19” environment while noting that the impact of COVID-19 continues. - FY2023-Q2RestatedAnnual report
「The Japanese economy during the six months ended 30 September showed signs of a moderate recovery under the “living with COVID-19” environment, partly due to the effects of various government policies.」
It describes an economic recovery under the “living with COVID-19” environment while noting that the impact of COVID-19 continues. - FY2023-Q1RestatedAnnual report
「Although the Japanese economy during the three months ended 30 June showed signs of a moderate recovery under the “living with COVID-19” environment, partly due to the effects of various government policies,」
It describes an economic recovery under the “living with COVID-19” environment while noting that the impact of COVID-19 continues. - FY2022Easing of the impact of the infection and expected continuationAnnual report
「Although the impact of COVID-19 has gradually eased and economic activity has been normalizing, with signs of a moderate recovery, the outlook remains uncertain due to the re-expansion of COVID-19, sharp foreign-exchange fluctuations associated with global monetary tightening, higher raw material costs, and supply constraints, among other factors.」
Although the impact of the infection is easing and economic activity is normalizing, the outlook remains uncertain due to the re-expansion of infections and other factors, and the impact of the infection has not been completely eliminated. - FY2022-Q3MaterialisedAnnual report
「COVID-19 has had wide-ranging effects on corporate activities and the economy. The Group (the Company and its consolidated subsidiaries) has also been affected by delays in sea transportation and restrictions on the movement of people in some overseas regions.」
The impact of COVID-19 continues to occur in practice, including delays in ocean transportation and restrictions on the movement of people in some overseas regions. - FY2022-Q2MaterialisedAnnual report
「COVID-19 has had wide-ranging effects on corporate activities and the economy. The Group (the Company and its consolidated subsidiaries) has also been affected by delays in product deliveries to customers and other issues resulting from delays in sea transportation.」
The impact of COVID-19 has emerged as a specific business impact in the form of delays in ocean transportation and delays in delivering products to customers. - FY2022-Q1MaterialisedAnnual report
「The Group (the Company and its consolidated subsidiaries) has also been affected, both domestically and overseas, by partial restrictions on sales activities involving visits to customers and by mandatory quarantine periods when traveling overseas and returning home, which have lengthened the time required for commissioning tests after delivery.」
The impact of COVID-19 continues to occur in practice in the form of restrictions on sales visits in Japan and overseas, quarantine when traveling abroad and returning home, and longer delivery trial-run periods. - FY2021-Q3MaterialisedAnnual report
「The global spread of COVID-19 has had wide-ranging effects on corporate activities and the economy. The Group has also been affected mainly overseas by partial restrictions on sales activities involving visits to customers and by mandatory quarantine periods when traveling overseas and returning home, which have lengthened the time required for commissioning tests after delivery.」
The impact of COVID-19 continues to occur in practice, including restrictions on overseas sales visits, quarantine when traveling abroad and returning home, and longer delivery trial-run periods. - FY2021-Q2RestatedAnnual report
「The Group, comprising the Company and its consolidated subsidiaries, has also been affected mainly overseas by partial restrictions on sales activities involving visits to customers and the inability to conduct some delivery trial runs performed to install machinery and ensure machining accuracy. Although it is difficult to predict when the COVID-19 pandemic will subside, conditions are expected to gradually normalize during the fiscal year under review.」
Restrictions on overseas sales visits and the partial inability to conduct delivery trial runs continue to occur in practice, while gradual normalization during the fiscal year under review is expected. - FY2021-Q1MaterialisedAnnual report
「The Group, comprising the Company and its consolidated subsidiaries, has also been affected mainly overseas by partial restrictions on sales activities involving visits to customers and the inability to conduct some delivery trial runs performed to install machinery and ensure machining accuracy. Although it is difficult to predict when the COVID-19 pandemic will subside, progress toward containment has been made, including the start of vaccination programs in the United States and the United Kingdom. Accordingly, accounting estimates relating to impairment of property, plant and equipment and the recoverability of deferred tax assets, among other matters, have been prepared on the assumption that conditions will gradually normalize from the fiscal year under review.」
Restrictions on overseas sales visits and the partial inability to conduct delivery trial runs continue to occur in practice. Meanwhile, accounting estimates are being prepared on the assumption of gradual normalization from the fiscal year under review, in light of the start of vaccination programs. - FY2020MaterialisedAnnual report
「The Group has also been affected by partial restrictions on sales activities aimed at securing new orders and the carryover of sales from some overseas projects to the following fiscal year or later.」
The impact of COVID-19 occurred throughout the fiscal year as specific business impacts, namely restrictions on sales activities and the carryover of sales from overseas projects. - FY2020-Q3MaterialisedAnnual report
「The Group (the Company and its consolidated subsidiaries) has also been affected by partial restrictions on sales activities aimed at securing new orders and by sales from some overseas projects being carried forward to the following fiscal year or later.」
It is stated that restrictions on sales activities due to COVID-19 and the carryover of sales from overseas projects actually occurred, showing that the previously identified risk of an impact on the economy and orders has emerged as a specific business impact. - FY2020-Q2First statedAnnual report
「Although employment conditions and the income environment in Japan improved during the six months ended 30 September, the economy was sharply pushed down by the impact of COVID-19 and remained in an uncertain situation. In the machine tool industry, in addition to the previously weak investment environment, orders were on a declining trend due to the impact of the infection, and there were months in which the value of orders decreased both month on month and year on year.」
It is stated for the first time that COVID-19 and the infectious disease significantly pushed down the domestic economy and manifested themselves as a declining trend in orders in the machine tool industry.